In insulinomas, which contain less CgA than the other non-β-cell tumors, serum CgA levels are not increased in the patients but measurement of serum CgA is a helpful indicator for tumor metastasis by the increasing CgA-secreting tumor mass [53-55]. This evidence concerns the gene CGA and pancreatic insulinoma.